✦ LIBER ✦

Priming for l-dopa-induced dyskinesia in Parkinson’s disease: A feature inherent to the treatment or the disease?

✍ Scribed by Agnès Nadjar; Charles R. Gerfen; Erwan Bezard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Possible role for chlorpheniramine in th

✍ Karamanakos, Petros N. ;Pappas, Periklis ;Marselos, Marios 📂 Article 📅 2007 🏛 Springer 🌐 Dutch ⚖ 107 KB

5-Hydroxy-tryptophan for the treatment o

✍ Tronci, Elisabetta; Lisci, Carlo; Stancampiano, Roberto; Fidalgo, Camino; Collu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 642 KB

2.274 Onset age or age for initial L-dop

✍ T. Kimura; M. Tomiyama; A. Arai; C. Suzuki; T. Kawarabayashi; M. Shoji 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

New pharmacological avenues for the trea

✍ Blandini, Fabio; Armentero, Marie-Therese 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 469 KB

Adenosine receptors and l-DOPA-induced d

✍ Fabio Blandini 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Animal models of Parkinson’s disease and

✍ Emma Lane; Stephen Dunnett 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 205 KB